Envoy Medical Inc. Class A Common Stock (COCH)
Stock · NASDAQ · Health Care
$0.6657as of 10/16/2026
Price chart
Active signals
COCH Signal Track Record
How signals performed across all stocks →What COCH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 44 | +0.2% | 52% | October 2, 2026 |
| Bollinger Band Breakout | 27 | +0.1% | 52% | August 14, 2026 |
| Bollinger Band Breakdown | 16 | -0.9% | 44% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 10 | +0.7% | 80% | September 18, 2026 |
| Any 20-session window (baseline) | +0.1% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About COCH
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; an…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 43
- Website
- www.envoymedical.com/
Fundamentals
- 1-day range
- $0.62$0.6365
- Market cap
- $52.34M
- P/E (trailing)
- —
- P/E (forward)
- -2.64
- EPS (trailing)
- $-0.65
- Dividend yield
- —
- Beta
- 2.05
- Avg. volume
- 120.2K
How Envoy Medical Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2023 annual results
Source: 10-K filed Apr 1, 2024 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Envoy Medical Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- COCHEnvoy Medical Inc. Class A Common Stock$0.668▲ 3.57%Market cap $52.34MP/E —$0.3625$0.9634
- APTAlpha Pro Tech Ltd. Common Stock$5.55▼ 2.97%Market cap $53.33MP/E 14.66$4.34$7.5
- MYOMyomo Inc. Common Stock$1.2▼ 7.69%Market cap $50.62MP/E —$0.605$1.89
- MAMOMassimo Group Common Stock$0.926▼ 0.43%Market cap $44.56MP/E 9.77$0.66$5.59
- MLSSMilestone Scientific Inc. Common Stock$0.33▲ 0.00%Market cap $41.13MP/E —$0.2181$0.5796
- ADSEWADS-TEC ENERGY PLC Warrant$0.21▼ 4.33%Market cap $38.90MP/E —$0.14$1.37
- NTRBNutriband Inc. Common Stock$6.22▼ 0.80%Market cap $35.43MP/E —$2.8$9.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| COCH Envoy Medical Inc. Class A Common Stock | $52.34M | — | $0.668 | ▲ 3.57% | $0.3625$0.9634 |
| APT Alpha Pro Tech Ltd. Common Stock | $53.33M | 14.66 | $5.55 | ▼ 2.97% | $4.34$7.5 |
| MYO Myomo Inc. Common Stock | $50.62M | — | $1.2 | ▼ 7.69% | $0.605$1.89 |
| MAMO Massimo Group Common Stock | $44.56M | 9.77 | $0.926 | ▼ 0.43% | $0.66$5.59 |
| MLSS Milestone Scientific Inc. Common Stock | $41.13M | — | $0.33 | ▲ 0.00% | $0.2181$0.5796 |
| ADSEW ADS-TEC ENERGY PLC Warrant | $38.90M | — | $0.21 | ▼ 4.33% | $0.14$1.37 |
| NTRB Nutriband Inc. Common Stock | $35.43M | — | $6.22 | ▼ 0.80% | $2.8$9.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Envoy Medical Submits Second FDA Module Of Its PMA Application For The Acclaim Cochlear Implant; Targets Final Clinical Submission In Q2 2027benzinga · 10/12/2026
- Envoy Medical Announces Delaware Chancery Court Dismissal With Prejudice Of Atlas Merchant Capital Spac Fund I's Claim That It Was Not Allowed To Redeem SharesBenzinga · 10/7/2026
- Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5Benzinga · 10/6/2026
- Envoy Medical Announces New Patents, Further Expanding Global Patent PortfolioYahoo · 9/22/2026
- Envoy Medical Granted Two Additional Global Patents Over Its IP PortfolioBenzinga · 9/22/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 9/11/2026
Insider Activity
Insider Actions →- Robert Potashnick · August 24, 2026 · Grant250.0K
- Brent T. Lucas · June 19, 2026 · Grant1.00M
- Brent T. Lucas · May 29, 2026 · Grant32.9K @ $0.599
- McKhann Chas · April 15, 2026 · Grant100.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 16.99M
- Total value held
- $11.29M
- Institutional holders
- 31
- Unknown7.65M
- Unknown6.25M
- Unknown881.7K
- Unknown625.0K
- Unknown521.8K
- Unknown212.7K
- Unknown187.6K
- Unknown111.0K
- Unknown77.9K
- Unknown73.9K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Envoy Medical Adds Two New Patents to Global Portfolio
Envoy Medical announced it has been granted two additional global patents, further expanding its intellectual property portfolio. This development strengthens the company's protection for its medical technologies. The stock is currently trading near its 52-week low, with an average analyst target of $2.00.
Envoy Medical Adds Two New Patents to Global Portfolio. Envoy Medical announced it has been granted two additional global patents, further expanding its intellectual property portfolio. This development strengthens the company's protection for its medical technologies. The stock is currently trading near its 52-week low, with an average analyst target of $2.00.